World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
131
Citations
66994
World Ranking
2390
National Ranking
1349

Stuart J. Schnitt publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stuart J. Schnitt sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 524 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stuart J. Schnitt D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stuart J. Schnitt sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 131 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stuart J. Schnitt is affiliated with Brigham and Women's Hospital in the United States. Their research primarily focuses on oncology, pathology, and breast cancer studies, with a significant publication record in these fields. The main fields of study include Medicine and Biochemistry, Genetics and Molecular Biology, with particular attention to subfields such as Oncology, Cancer Research, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, and Pulmonary and Respiratory Medicine.

Their work addresses various topics related to breast cancer, cancer genomics, and diagnostic methods, including a focus on advanced breast cancer therapies and the application of artificial intelligence in cancer detection. Additional topics of interest include HER2/EGFR in cancer research as well as radiomics and machine learning in medical imaging.

Frequent co-authors collaborating with Stuart J. Schnitt include Elizabeth A. Mittendorf, Tari A. King, Sara M. Tolaney, Laura C. Collins, and Gabrielle M. Baker.

The scientist publishes regularly in several venues, with the most frequent publication outlets being:

  • Cancer Research
  • Modern Pathology
  • Annals of Surgical Oncology
  • npj Breast Cancer
  • Journal of Clinical Oncology

Recent papers authored or co-authored by Stuart J. Schnitt include:

  • "The 2019 World Health Organization classification of tumours of the breast," 2020, Histopathology
  • "ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer," 2023, Annals of Oncology
  • "The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice," 2020, The Journal of Pathology
  • "Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer," 2022, JAMA Oncology
  • "Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer," 2020, npj Breast Cancer

Best Publications

  • WHO classification of tumours of the breast

    Sunil R. Lakhani;Ian O. Ellis;Stuart J. Schnitt;Puay Hoon Tan

  • Molecular Definition of Breast Tumor Heterogeneity

    Michail Shipitsin;Lauren L. Campbell;Pedram Argani;Stanislawa Weremowicz

  • Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

    Fitzgibbons Pl;Page Dl;Weaver D;Thor Ad

  • Molecular characterization of the tumor microenvironment in breast cancer

    Minna Allinen;Rameen Beroukhim;Li Cai;Cameron Brennan

  • Society of surgical oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages i and II invasive breast cancer

    Meena S. Moran;Stuart J. Schnitt;Armando E. Giuliano;Jay R. Harris

  • Prognostic Factors in Breast Cancer

    Patrick L. Fitzgibbons;Patrick L. Fitzgibbons;David L. Page;Donald Weaver;Ann D. Thor

  • Breast cancer prognostic classification in the molecular era: the role of histological grade

    Emad A. Rakha;Jorge S. Reis-Filho;Frederick Baehner;David J. Dabbs

  • Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer

    Lawrence F Brown;Brygida Berse;Robert W Jackman;Kathi Tognazzi

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Sunil Badve;David J. Dabbs;Stuart J. Schnitt;Frederick L. Baehner

  • Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.

    Asa J. Nixon;Donna Neuberg;Daniel F. Hayes;Rebecca Gelman

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma in Situ, Metastatic Tumor Deposits and Areas for Further Research

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • A Nonapoptotic Cell Death Process, Entosis, that Occurs by Cell-in-Cell Invasion

    Michael Overholtzer;Arnaud A. Mailleux;Ghassan Mouneimne;Guillaume Normand

  • Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence

    Catherine C. Park;Michihide Mitsumori;Asa Nixon;Abram Recht

  • A prospective study of benign breast disease and the risk of breast cancer.

    Stephanie J. London;James L. Connolly;Stuart J. Schnitt;Graham A. Colditz

  • Specificity of HercepTest in Determining HER-2/neu Status of Breast Cancers Using the United States Food and Drug Administration–Approved Scoring System

    Timothy W. Jacobs;Allen M. Gown;Hadi Yaziji;Melissa J. Barnes

  • The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast‐conserving surgery and radiation therapy

    Stuart J. Schnitt;Anthony Abner;Rebecca Gelman;James L. Connolly

  • Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor positive breast cancer

    Rinath Jeselsohn;Roman Yelensky;Gilles Buchwalter;Gilles Buchwalter;Garrett Frampton

  • Diagnostic architectural and dynamic features at breast MR imaging: Multicenter study

    Mitchell D. Schnall;Jeffrey Blume;David A. Bluemke;Gia A. DeAngelis

  • Luminal B breast tumors are not HER2 positive – authors' response

    Rulla May Tamimi;Rulla May Tamimi;Stuart Jay Schnitt;Graham A. Colditz;Graham A. Colditz;Laura Christine Collins

Frequent Co-Authors

James L. Connolly
James L. Connolly Beth Israel Deaconess Medical Center
Rulla M. Tamimi
Rulla M. Tamimi Cornell University
Jay R. Harris
Jay R. Harris Brigham and Women's Hospital
Abram Recht
Abram Recht Beth Israel Deaconess Medical Center
Graham A. Colditz
Graham A. Colditz Washington University in St. Louis
Rebecca Gelman
Rebecca Gelman Harvard University
Nadine Tung
Nadine Tung Beth Israel Deaconess Medical Center
Judy Garber
Judy Garber Harvard University
Bernard Rosner
Bernard Rosner Harvard University
Andrea L. Richardson
Andrea L. Richardson Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine offers diverse career paths beyond the traditional MD. Online degrees have made it easier for aspiring healthcare professionals to access high-quality education and find flexible study options that fit their schedules.

For those aiming for advanced clinical roles, exploring dnp programs online can help you reach the highest level of nursing practice while balancing work commitments. Alternatively, if you wish to start your career quickly, a lpn fast track program provides a fast entry point into nursing with practical training that leads directly to patient care roles.

Mental health is a growing field, and those wanting to specialize can consider the shortest pmhnp program to become a Psychiatric Mental Health Nurse Practitioner with an accelerated, focused curriculum. For those interested in the management side of healthcare, a healthcare administration degree online opens doors to leadership roles in hospitals, clinics, and other healthcare settings.

Each pathway offers unique advantages and fulfills pressing needs in the healthcare workforce, making online study a viable and increasingly popular choice.

Best Scientists Citing Stuart J. Schnitt

Trending Scientists

Recently Published Articles